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ttp://dx.doi.org/10.1016/j.ajpath.2013.01.035Cigarette smoking damages the extracellularmatrix in a variety of locations, leading to atherosclerotic plaque
instability and emphysematous lung destruction, but the underlying mechanisms remain poorly understood.
Here, we sought to determine whether exposure of human macrophages, a key participant in extracellular
matrix damage, to tobacco smoke extract (TSE) induces the release of microvesicles (MVs; or microparticles)
with proteolytic activity; themajor proteases involved; and the cellular mechanisms thatmightmediate their
generation. We found that MVs released from TSE-exposed macrophages carry substantial gelatinolytic and
collagenolytic activities that surprisingly can be predominantly attributed to a single transmembrane
protease of the matrix metalloproteinase (MMP) superfamily (namely, MMP14). Flow cytometric counts
revealed that exposure of human macrophages to TSE for 20 hours more than quadrupled their production of
MMP14-positive MVs (control, 1112  231; TSE-induced, 5823  2192 MMP14-positive MVs/mL of condi-
tioned medium; means  SEM; nZ 6; P < 0.01). Our results indicate that the production of these MVs by
human macrophages relies on a series of regulated steps that include activation of two mitogen-activated
protein kinases (MAPKs, i.e., the JunN-terminal kinase and p38MAPK), and thenMAPK-dependent induction
and maturation of cellular MMP14, a remarkable accumulation of MMP14 into nascent plasma membrane
blebs, and ﬁnally caspase- and MAPK-dependent apoptosis and apoptotic microvesicle generation. Proteo-
lytically activeMVs inducedby tobaccosmokemaybenovelmediators of clinical importantmatrix destruction
in smokers. (Am J Pathol 2013, 182: 1552e1562; http://dx.doi.org/10.1016/j.ajpath.2013.01.035)Supported by American Heart Association, Great Rivers Afﬁliate
Beginning Grant-In-Aid (M.L.L.), NIH grant R01HL73898 (K.J.W.), and
a Temple University Department of Medicine Career Development
Research Award (M.L.L.).
A preliminary report of this work was presented at the 79th European
Atherosclerosis Society Congress (June 2011) in Göteborg, Sweden.22Microvesicles (MVs), also known as microparticles, are small
membranous structures that are released from cells during
activation or apoptosis.1e7 Recent studies from our labora-
tory,5 as well as other groups,8,9 have shown that exposure to
tobacco smoke, an important risk factor for atherosclerosis and
respiratory diseases, increases MV generation from cultured
human cells in vitro5 and in the circulation of humans in vivo.8,9
The potential pathophysiological involvement of MVs in
different diseases has attracted considerable attention in
the past few years.1e7 Macrophages play key roles in the
destabilization and rupture of atherosclerotic plaque10e12stigative Pathology.
.and in emphysematous lung destruction13,14 through their
expression of a variety of proteases.11,13,15 It has not been
previously explored whether MVs released from human
macrophages after tobacco smoke exposure can cause
collagen degradation, thereby contributing to extracellular
Smoke Induces Proteolytic Microvesiclesmatrix damage in the cardiovascular and respiratory systems
in smokers.
In the current study, we sought to determine whether expo-
sure of human macrophages to tobacco smoke extract (TSE)
induces the release of MVs with proteolytic activity, what the
nature of the major proteases on smoke-induced macrophage
MVs might be, and what cellular mechanisms might be
responsible for their generation. Given the vesicular structure
of MVs, three general types of proteases appeared possible:
i) transmembrane,16e18 ii) intracellular,19 and iii) non-
transmembrane but surface-bound.20 Surprisingly, we found
that smoke-induced macrophage MVs carry signiﬁcant gelat-
inolytic and collagenolytic activities that could be predomi-
nantly attributed to a single transmembrane protease of the
matrix metalloproteinase (MMP) superfamily (ie, MMP14),
which is also known as the membrane type 1 MMP.16,21,22
Materials and Methods
Reagents and Antibodies
PhosphoPlus antibody kits against three major mitogen-
activated protein kinases (MAPK): i) Jun N-terminal kinase
(JNK) (phospho-Thr183/Tyr185, catalog #9250), ii) p38
MAPK (phospho-Thr180/Tyr182, catalog #9211), and iii)
extracellular signal-regulated kinase (ERK) (phospho-
Thr202, catalog #9100) were purchased from Cell Signaling
Technology (Beverly, MA). Monoclonal antibodies against
human MMP14 were purchased from Abcam (Cambridge,
MA) or R&D Systems (Minneapolis, MN). Phycoerythrin-
labeled annexin-V was purchased from BD Pharmingen
(San Jose, CA). Inhibitors of JNK (SP600125, catalog
#5567), p38 (SB202190, catalog #7067), and ERK (U0126,
catalog #U120) were obtained from Sigma-Aldrich (St.
Louis, MO). The pan-caspase inhibitor (Z-VAD-FMK) was
purchased from R&D Systems. Gelatin from porcine skin
(119K0062) and native collagen from human placenta
(C7774) were purchased from Sigma-Aldrich.
Preparation of Tobacco Smoke Extract
Research-grade cigarettes were obtained from the Reference
Cigarette Program at the University of Kentucky (Lexington,
KY). Full-strength stock tobacco smoke extract (TSE, 100%)
was prepared by extracting mainstream smoke from four
cigarettes through 10 mL of phenol red-free RPMI 1640
medium containing 0.2% bovine serum albumin (BSA), at
one cigarette per 7 to 8minutes, simulating the burning rate of
typical smoking.5,23e26 We followed our previous method,5
which was modiﬁed here to improve extraction efﬁciency
by using a Kontes gas washing bottle (Kimble/Kontes Glass
Co., Vineland, NJ) that allows the system to be sealed and
increases the travel distance for smoke bubbles through the
medium. Stock preparations of TSE were adjusted to a pH of
7.4 and then sterilized by passage through a ﬁlter with
a 0.22-mm size cut-off. Our initial studies indicated thatThe American Journal of Pathology - ajp.amjpathol.orga single freeze-thaw cycle did not alter the biological effects of
TSE on cultured cells, and therefore TSE was aliquoted and
stored at80C. To ensure consistency among preparations,
each batch of TSE was standardized according to its absor-
bance at 320 nm5,27,28 and re-standardized to its potency to
induce apoptosis of THP-1 monocytic cells5 by comparison
with aliquots of a single standard preparation that was made
at the beginning of the study.
Cell Culture and Differentiation
Human THP-1 monocytic cells were differentiated into
macrophage-like cells (called THP-1macrophages)4,5 (ATCC)
by transient exposure to phorbol 12-myristate 13-acetate
(PMA) (Sigma-Aldrich) by following previously described
methods with minor modiﬁcations.29,30 Brieﬂy, THP-1
monocytic cells were differentiated with 50 ng/mL PMA for
48 hours. The resulting adherent cultured THP-1macrophages
were rinsed with warmed phosphate-buffered saline (PBS),
followed by48hourswash-out incubation in freshRPMI 1640/
10% fetal bovine serum, without PMA, to minimize ongoing
effects of this compound. Primary human monocyte-derived
macrophages (hMDMs) were prepared from fresh buffy
coats by selecting monocytes via plate adherence, followed by
differentiation into macrophages as described.4,5,31 These two
cell types are commonly used as models of the macrophages in
atheromata4,5,32 and in pulmonary alveoli.33e36
At the beginning of each experiment, THP-1 macro-
phages or primary hMDMs were transferred to serum-free
RPMI 1640 medium/BSA supplemented with different
concentrations of TSE, ranging from 0% (control) to 2.5%
(v:v, the highest concentration being approximately equiv-
alent to a 60 kg person smoking 2 packs of cigarettes), and
then incubated at 37C for 0 to 20 hours. In time-course
studies, all groups of cells were simultaneously placed into
serum-free medium and simultaneously harvested; TSE was
added at indicated times before harvest. In experiments
using Z-VAD-FMK or MAPK inhibitors, the compounds
were added to cells 1 hour before the addition of TSE and
remained until the end of the study, at concentrations of 50
mmol/L Z-VAD-FMK, 10 mmol/L SP600125, 10 mmol/L
SB202190, and 10 mmol/L U0126.
Isolation and Immunoblotting of Cultured Cells and
Their MVs
After treatment of THP-1 macrophages or hMDMs with or
without TSE, the conditioned medium was harvested and
centrifuged twice at 1500 g for 10 minutes to eliminate cell
debris and then at 100,000 g for 30 minutes at 4C to pellet
MVs. The MVs were then washed by resuspension in PBS,
then ultracentrifuged again, and the washed pellet was
subsequently resuspended in fresh RPMI 1640 with 0.1%
Triton X-100 for assessment of proteolytic activities or in cell
lysis buffer for immunoblots. For immunoblots, cells and
isolated MVs were lysed in a buffer containing 20 mmol/L1553
Li et alTris/HCl, pH 7.4, 150 mmol/L NaCl, 1 mmol/L EGTA, 1%
Triton X-100, 1% sodium deoxycholate, 1 mmol/L EDTA,
2.5 mmol/L sodium pyrophosphate, 1 mmol/L Na3VO4 (an
inhibitor of protein tyrosine phosphatases), and a commercial
protease inhibitor cocktail tablet (Roche Diagnostics GmbH,
Mannheim, Germany) for 30 minutes on ice. Samples (50 to
80 mg protein/lane) were electrophoresed through a 4% to
15% precast linear gradient polyacrylamide gel, followed by
a transfer of proteins to nitrocellulose membranes and then
immunoblotting, as described.5 Bands were visualized using
an enhanced chemiluminescence detection kit (Thermo
Scientiﬁc, Waltham, MA). Signals were quantiﬁed using
ImageJ version 1.45 densitometry software and normalized
in each independent experiment to values from control cells.
Assays of Proteolytic Activities of Isolated MVs
We used three separate methods to assess the proteolytic
activities of MVs from control and TSE-exposed cells. The
ﬁrst method used ﬂuorogenic substrate I (ES001; R&D
Systems), which harbors the consensus sequence Mca-Pro-
Leu-Gly-Leu-Dpa-Ala-Arg-NH2 that is cleaved by MMP1,
MMP2,MMP7,MMP8,MMP9,MMP12,MMP13,MMP14,
MMP15, and MMP16. Cleavage of ﬂuorogenic substrate I
generates a ﬂuorescent product. We pre-warmed isolated
MVs and 10 mmol/L ﬂuorogenic substrate I in separate
aliquots of activity buffer (25 mmol/L Tris/HCl, pH 8.0,
containing 2.5 mmol/L ZnCl2, and 3 mmol/L CaCl2) at 37C
for 0.5 hours. These aliquots were mixed to initiate the
enzymatic reaction in a ﬁnal volume of 100 mLwithin wells of
a 96-well plate at 37C. Cleavage of the substrate was
kinetically monitored at 320-nm excitation and 405-nm
emission every 20 minutes for 2 hours.
The secondmethodwe used to assess proteolytic activity in
control and TSE-induced MVs was gelatin zymography,
which was optimized using features taken from several pub-
lished protocols.16,37,38 In brief, we prepared 8% SDS-PAGE
gels containing 1 mg/mL gelatin. Homogenates of isolated
MVs were loaded onto these gels under nonreducing condi-
tions, and were run at 100 V for 120 minutes with molecular
weight standards (Lonza 50550, Walkersville, MD). Gels
were then washed four times in zymogram renaturing buffer
(LC2670; Invitrogen, Grand Island, NY) and incubated
overnight in zymogram development buffer (LC2671; Invi-
trogen) at 37C. Gels were then stained with 0.2%Coomassie
Blue R-250 followed by two rounds of destaining in 55%
methanol and 7%acetic acid. The gelswere scanned for image
capture and densitometric analysis using the Epson Perfection
V700 Photo Flatbed Scanner (Long Beach, CA).
The third method to assess proteolytic activity in MVs
was native collagen zymography, which we also optimized
using features taken from several published protocols.16,39,40
We made our native collagen gels by pouring them under
controlled temperature and pH to avoid collagen denatur-
ation. MV homogenates were loaded onto 8% SDS-PAGE
gels containing 0.5 mg/mL of collagen under nonreducing1554conditions, and were then run and processed exactly the
same as the gelatin zymograms.
Flow Cytometry
Flow cytometry ofMVs and cells was performed according to
our published protocols.4,5 In brief, at the end of each incu-
bation, culture supernatants were ﬁxed by the addition of
ﬁltered paraformaldehyde to a ﬁnal concentration of 1%, and
then supplemented with latex beads as a reference for MV
counts. The number ofMVs in each sample was quantiﬁed by
ﬂow cytometry (FACSCalibur, Becton Dickinson, Franklin
Lakes, NJ), using gating criteria based on particle size, as
detected by forward scatter, and surface exposure of phos-
phatidylserine (PS), as detected by staining with PE-labeled
annexin-V (BD Pharmingen).4,5 The portion of these PS-
positive MVs meeting standard size criteria that were also
MMP14-positive was quantiﬁed by simultaneous staining
with anti-human MMP14 monoclonal antibody (ab78738;
Abcam), followed by ﬂuorescein isothiocyanate (FITC)-
labeled goat anti-mouse IgG secondary antibody (Abcam).
Adherent monolayers of THP-1 macrophages and hMDMs
were scraped and ﬁxed by suspension in 1% para-
formaldehyde and then 70% ethanol. Late-stage apoptosis
was assessed by TUNEL (APO-DIRECT kit, BD Pharmin-
gen) and was also quantiﬁed by ﬂow cytometry.
Confocal Microscopy
For confocal ﬂuorescence microscopy, adherent THP-1
macrophages were incubated without (control) or with
2.5% TSE for 20 hours at 37C, and were then ﬁxed on the
plates with 4% paraformaldehyde in PBS on ice for 10
minutes. The ﬁxed cells were then washed twice with PBS,
followed by a blocking solution (1% BSA and 0.1% Triton
X-100 in PBS) for 60 minutes at room temperature. The cells
were simultaneously incubated with 10 mg/mL primary anti-
humanMMP14 antibody (Abcam) and 10 mL/mL PE-labeled
annexin V, thereafter, in the presence of 1 mmol/L CaCl2, in
the dark at 4C overnight. The cells were washed three times
with 0.2% BSA in PBS to remove unbound primary antibody
and annexin V, and then incubated with 1:2000 FITC-labeled
goat anti-mouse IgG secondary antibody in PBS with 1% of
BSA for 1 hour. The stained cells were analyzed with a Leica
TCS SP5 ﬂuorescent confocal microscope (Leica Micro-
systems Inc., Buffalo Grove, IL).
Statistical Analysis
Normally distributed data are shown as means  SEM (nZ
4 to 6). Comparisons among three or more groups were
performed using one-way analysis of variance followed by
the Student-Newman-Keuls (SNK) test, with P < 0.05
considered signiﬁcant. Comparisons between two groups
used the Student’s unpaired, two-tailed t-test. Comparisons
between two groups of non-normally distributed data used
the Mann-Whitney rank-sum test.ajp.amjpathol.org - The American Journal of Pathology
Figure 1 Exposure of human macrophages to
tobacco smoke induces the release of potently
proteolytic microvesicles in which MMP14 is the
predominant gelatinase and collagenase. Micro-
vesicles were puriﬁed from the conditioned media
of human THP-1 macrophages (3  106 cells) (A,
C, D, and E), and hMDMs (0.8  106 cells) (B and
F) that had been incubated for 20 hours at 37C in
Dulbecco’s modiﬁed Eagle’s medium/BSA supple-
mented with buffer (Control MVs) or 2.5% TSE
(TSE-MVs). A and B: Representative kinetic curves
for the cleavage of ﬂuorogenic substrate 1, a known
substrate for MMPs, by control and TSE-induced MVs
(TSE-MVs) from the two preparations of human
macrophages. These curves indicate that our
measurements were taken without saturation of the
assay. For additional validation, we also tested
ﬂuorogenic substrate I without MVs (Substrate
control), 2.5% TSE with no MVs (TSE), and TSE-MVs
supplemented with 50 mmol/L tissue inhibitor of
metalloproteinase 3 (TIMP3), a known inhibitor of
MMPs (TSE-MVsþTIMP3) (A). P< 0.001 by analysis
of variance at each time point after 20 minutes, but
the only values signiﬁcantly different from the
other four groups came from TSE-MVs (P < 0.05,
Student-Newman-Keuls test) (A). P < 0.05 by
Student’s t-test at each time point after 20 minutes
(B). CeF: Human macrophage-derived MVs were
extracted and then analyzed by gelatin zymography
(C), and immunoblotting using anti-MMP14 anti-
bodies (D) and native collagen zymography (E and
F). Zymograms and immunoblots (shown in CeF)
display images of full-length lanes representative
of more than three independent experiments.
Indicated are molecular-weight markers in kilo-
daltons, as well as pro-MMP14, mature MMP14
(MMP14), and their dimers. All other bands were
faint. Dark ﬂecks (shown in E and F) are focal
precipitates of native collagen that form inadver-
tently when these gels cool and solidify after
pouring.
Smoke Induces Proteolytic MicrovesiclesResults
Exposure of Human Macrophages to Tobacco Smoke
Induces the Release of Potently Proteolytic
Microvesicles in Which MMP14 Is the Predominant
Gelatinase and Collagenase
To determine whether exposure of human macrophages to
tobacco smoke induces the release of MVs with proteolytic
activity,webeganby isolatingMVs from the conditionedmedia
of control and TSE-treated human THP-1 macrophages and
primary hMDMs, and then examining the ability of these
particles to cleave ﬂuorogenic substrate I, a commonly used
artiﬁcial substrate for MMPs. Based on the linear portion of the
reaction curves, TSE-MVs showed striking proteolytic activity,
reaching 3 times the values from control MVs (Figure 1, A
and B). Our TSE preparation, which is washed away during
isolation of MVs, contained no detectable protease activityThe American Journal of Pathology - ajp.amjpathol.org(Figure 1A).Next, to determine thenature of themajorproteases
on smoke-inducedMVs, we showed that their activity is nearly
completely inhibited by the tissue inhibitor ofmetalloproteinase
3 (Figure 1A), indicating one or more MMPs. To examine
activities against components of the extracellular matrix, we
performed zymography of MV homogenates, using two rele-
vant substrates e namely, gelatin (ie, partially hydrolyzed
collagen) (Figure 1C) and native triple-helical collagen
(Figure 1, E and F). Images of full-length lanes are displayed
(Figure 1, CeF) to allow detection of all active enzymes.
Surprisingly, we found signiﬁcant gelatinolytic and collageno-
lytic activity carried by smoke-induced macrophage MVs that
could be attributed predominantly to a single transmembrane
protease of the MMP superfamily e namely, MMP14, the
identity of which was conﬁrmed by molecular weight from
zymography (Figure 1, C, E, and F) and from immunoblot-
ting with a speciﬁc monoclonal antibody against MMP14
(Figure 1D). The ﬁnding of collagenolytic activity strongly1555
Figure 2 Exposureofhumanmacrophages to TSE
inducesMMP14 expression, activation, accumulation
in small circumscribed cell-surface domains, and
release on microvesicles. A and B: Quantiﬁcations
and representative immunoblots of total MMP14
content of human THP-1 macrophages (A) and
primary hMDMs (B) after exposure to 2.5% TSE for
0 to 20 hours. All cells were harvested simulta-
neously; TSE was added at the indicated times before
harvest. P< 0.001 by analysis of variance; *P< 0.05
and **P < 0.01 versus values at 0 hours by the
Student-Newman-Keuls post hoc test. C: Confocal
ﬂuorescent micrographs of representative THP-1
macrophages that were incubated without (Control)
or with 2.5% TSE for 20 hours, as indicated, and then
stained simultaneously with anti-human MMP14
antibodies (detected with green FITC-labeled
secondary antibodies) and phycoerythrin-labeled
annexin V (red, which preferentially binds exterior-
ized phosphatidylserine). Confocal slices were taken
to visualize the upper surface of the cells. The yellow
color in themerged images (Merge) demonstrates co-
localization of the two labels. Arrows indicate
examples of the small, circumscribed, cell-surface
domains that stain intensely for both MMP14 and
exteriorized PS and exhibit the same size as TSE-
induced MVs, consistent with enrichment of MMP14
innascentmembraneblebs. ScalebarZ1mm.D:MVs
from control and TSE-treated THP-1 macrophages
were analyzed by ﬂow cytometry. Displayed are
representative dot plots of staining by primary
antibodies against MMP14 (detected with FITC-
labeled secondary antibodies) versus annexin
V-phycoerythrin staining (indicating surface PS
exposure). The largeupper right rectangular regions
in each dot plot indicate the subset of MVs that are
MMP14-positive (MMP14D MVs). The lower-right
rectangles indicate MVs that did not meet our
threshold for MMP14 staining (MMP14L MVs). EeH:
Concentrations of total or MMP14-positive MVs in
conditioned media from control and TSE-exposed
THP-1 macrophages (E and F) and primary hMDMs
(G and H), as assessed by ﬂow cytometry. *P < 0.05
and **P < 0.01 versus the control values by the
unpaired two-tailed Student’s t-test.
Li et alsuggests a potential role for smoke-induced macrophage MVs
in destabilizing atherosclerotic plaques41e43 and damaging lung
tissues13,44e46 in smokers.
Exposure of Human Macrophages to TSE Induces
MMP14 Expression, Activation, Accumulation in Small,
Circumscribed Cell-Surface Domains, and Release on
Microvesicles
To investigate cellular mechanisms that are responsible for
the production and release of proteolytically active MVs
from smoke-exposed human macrophages, we focused on
the effects of TSE on induction, activation, and membrane
accumulation of MMP14, the dominant gelatinase and
collagenase we found on macrophage MVs (Figure 1).
Tobacco smoke exposure of human THP-1 macrophages
(Figure 2A) and primary hMDMs (Figure 2B) signiﬁcantly1556increased the cellular content of both inactive pro-MMP14
and active mature MMP14 in a time-dependent manner,
which by 20 hours exceeded a sevenfold induction in the
primary cells. Dose-dependent induction of cellular MMP14
by TSE is shown in Supplemental Figure S1. Importantly,
the majority of human macrophage MMP14 after 20 hours
of smoke exposure was the active, mature form (Figure 2, A
and B, and Supplemental Figure S1).
To document MMP14 display on the surface of TSE-
exposed human macrophages, we used ﬂuorescent confocal
microscopy. These images demonstrate a massive induction
of cell-surface MMP14 on smoke-exposed THP-1 macro-
phages compared to the control cells, which had essentially
no detectable MMP14 on their surface (Figure 2C). These
results conﬁrm and extend our ﬁndings with immunoblots
of whole-cell homogenates (Figure 2A). Macrophages
abnormally linger within atherosclerotic plaques47e50 andajp.amjpathol.org - The American Journal of Pathology
Figure 3 Apoptosis is required for the generation of proteolytically active, MMP14-positive microvesicles from TSE-exposed human macrophages. A and B:
THP-1 macrophages were pre-incubated for 1 hour without (Control, TSE) or with 50 mmol/L Z-VAD-FMK, a pan-caspase inhibitor (CASPi), and then sup-
plemented with buffer (Control) or 2.5% TSE, as indicated, followed by an additional 20-hour incubation. Displayed are the concentrations of total (A) and
MMP14-positive (B) MVs in conditioned media, as assessed by ﬂow cytometry. P < 0.01 by analysis of variance; **P < 0.01 and ***P < 0.001 for experimental
versus control values; yyP < 0.01 and yyyP < 0.001 for CASPi-TSE versus TSE values (Student-Newman-Keuls test). C: Representative kinetic curves for the
cleavage of ﬂuorogenic substrate 1 by MVs isolated from the same conditioned media (shown in A and B). P < 0.001 by analysis of variance at each time point
after 20 minutes, but the only values signiﬁcantly different from the other two groups came from TSE-MVs (P < 0.01, Student-Newman-Keuls test). D and E:
Representative gelatin (D) and native collagen (E) zymography of MVs isolated from the same conditioned media as (shown in AeC). F: Representative
immunoblots of total MMP14 content of THP-1 macrophages that were treated (shown in AeE).
Smoke Induces Proteolytic Microvesicleswithin emphysematous lung tissues13,45,46; induction of
active MMP14 on their cell surface by tobacco smoke could
contribute to extracellular matrix destruction in these
settings.
Our confocal images show a remarkable concentration of
cell-surface MMP14 in small, circumscribed domains rich in
exteriorized PS, a marker of MV generation (Figure 2C).
These domains exhibit approximately the same size as MVsThe American Journal of Pathology - ajp.amjpathol.org(approximately 1 mm) and resemble published images of
microvesicle release.51,52 Thus, smoke-exposed macro-
phages preferentially localize MMP14 into nascent plasma
membrane blebs, presumably as part of the export of this
molecule onto MVs. Next we used ﬂow cytometry with the
same two stains for MMP14 and exteriorized PS, along with
size gating by forward scatter, to analyze the conditioned
medium of THP-1 macrophages (Figure 2, DeF) andFigure 4 Activation of the JNK and p38 MAPKs
is required for TSE-induced expression of MMP14
by human macrophages. A and B: Representative
immunoblots of phosphorylated (p) and total
MAPKs (JNK, p38, ERK) after the indicated periods
of exposure of THP-1 macrophages (A) and primary
hMDMs (B) to 2.5% TSE. All cells were harvested
simultaneously; TSE was added at the indicated
times before harvest. C and D: Quantiﬁcations and
representative immunoblots of total MMP14
content of THP-1 macrophages (C) and primary
hMDMs (D) that were pretreated for 1 hour without
(control, dimethyl sulfoxide) or with the indicated
MAPK inhibitors (i), followed by 20-hour exposure
to 0% (control) or 2.5% TSE. These quantiﬁcations
come from three to ﬁve independent experiments.
P < 0.01 by analysis of variance; *P < 0.05 and
**P < 0.01 for experimental versus control values;
yP < 0.05 for values from cells treated with sup-
plemented TSE versus TSE alone (Student-Newman-
Keuls test).
1557
Figure 5 Activation of the JNK, especially p38
MAPKs is required for TSE-induced apoptosis and the
generation of total and MMP14-positive MVs from
human macrophages. A: Quantiﬁcations of TUNEL-
positive THP-1 macrophages by ﬂow cytometry
after the same treatments (as in Figure 4C) (ie, with
or without the indicated MAPK inhibitors, with or
without TSE). B: Representative histograms of
TUNEL staining of hMDMs after the same treatments
(as in Figure 4C). Displayed are events (y axis) versus
FITC-TUNEL staining (x axis). Note that the x axis
scale is logarithmic. C andD: Concentrations of total
(C) and MMP14-positive (D) MVs in conditioned
media, assessed by ﬂow cytometry, from THP-1
macrophages after the same treatments (as in
Figure 4C). Quantiﬁcations in each panel come from
four to six independent experiments. E: Represen-
tative dot plots from ﬂow cytometry of conditioned
medium from primary hMDMs after the same treat-
ments (as in Figure 4C). Displayed are signals from
FITC-labeled anti-MMP14 antibodies (y axis) versus
phycoerythrin-annexin V (x axis). In each dot plot,
events within the enclosed regions represent
MMP14þ-MVs and MMP14-MVs, as indicated. P <
0.001 by analysis of variance; ***P < 0.001 for
experimental versus control values; yP< 0.05, yyP<
0.01, yyyP< 0.001 for values from cells treated with
supplemented TSE versus TSE alone (Student-
Newman-Keuls test).
Li et alprimary hMDMs (Figure 2, G and H) after a 20-hour
exposure to 0% (controls) or 2.5% TSE. These results
show that tobacco smoke substantially increased the
production of total MVs (Figure 2, D, E, and G) and
MMP14-positive MVs (Figure 2, D, F, and H). Of note, the
majority of smoke-induced MVs carried detectable amounts
of MMP14 (comparing the enumerations in Figure 2F and
2H versus 2E and 2G), indicating widespread proteolytic
activity. This result is also consistent with the images in
Figure 2C, in which nearly all annexin V-positive regions of
the cell surface were also stained for MMP14.
Apoptosis Is Required for the Generation of
Proteolytically Active MMP14-Positive Microvesicles
from TSE-Exposed Human Macrophages
Apoptosis is a major mechanism for microvesicle gen-
eration.3e7 Our confocal images show that TSE induces exte-
riorization of PS on the cell surface, which can be a sign of
early-stage apoptosis, although as previously noted, the
binding of annexin V was concentrated in small circumscribed
domains, indicating only incomplete loss of membrane asym-
metry (Figure 2C). Consistent with prior literature in other cell
types,53e55 including human monocytes,5 we found that
exposure of THP-1 macrophages to TSE for 20 hours1558induced dose-dependent TUNEL staining, a deﬁnitive marker
of late-stage apoptosis (Supplemental Figure S2, A and B).
Pretreatment of these macrophages with a caspase inhibitor
signiﬁcantly attenuated TSE-induced apoptosis (Supplemental
Figure S2B), and the inhibitor almost completely blocked
smoke-induced generation of total and MMP14-positive MVs
(Figure 3, A and B). More importantly, caspase inhibition
abolished TSE-induced production of MVs with proteolytic
activities against ﬂuorogenic substrate I (Figure 3C), gelatin
(Figure 3D), or native collagen (Figure 3E). Similar to our prior
results on the regulation of tissue factor,5 caspase inhibition did
not affect the induction of cellular MMP14 expression by TSE
(Figure 3F), implying an effect solely on MV release. Thus,
inhibition of apoptosis in this context does not affect the
induction of abundant amounts of mature MMP14 in the cells
(Figure 3F), but dramatically inhibits the release of this
MMP14 on MVs (Figure 3).
Activation of the JNK, Especially the p38 MAPKs, Is
Required for TSE-Induced Expression of MMP14 by
Human Macrophages, Apoptosis, and the Generation of
Proteolytically Active, MMP14-Positive MVs
Nextwe focusedonmechanisms for smoke-induced expression
of MMP14 by human macrophages. Consistent with priorajp.amjpathol.org - The American Journal of Pathology
Figure 6 Activation of the JNK and p38 MAPKs is required for TSE-
induced generation of proteolytically active MVs from human macro-
phages. A: Human THP-1 macrophages were pre-incubated for 1 hour
without [control, dimethyl sulfoxide (DMSO)] or with the indicated MAPK
inhibitors, then supplemented with buffer (Control) or 2.5% TSE, followed by
additional 20-hour incubation. Displayed are kinetic curves for the cleavage
of ﬂuorogenic substrate 1 by MVs isolated from the conditioned media of
these cells. P < 0.001 by analysis of variance at each time point after 20
minutes. Each member of the upper cluster of values (DMSO-TSE MVs, TSE
MVs, and ERKi-TSE MVs) was signiﬁcantly different from each member of the
lower cluster of values (p38i-TSE MVs, JNKi-TSE MVs, and Control MVs),
P < 0.05, by the Student-Newman-Keuls test. B and C: Representative
gelatin (B) and collagen (C) zymography of MVs isolated from the condi-
tioned medium of THP-1 macrophages after the same treatments (as shown
in A). AeC are representative from at least three independent experiments.
ERKi, ERK inhibitor; JNKi, JNK inhibitor; p38i, p38 inhibitor.
Smoke Induces Proteolytic Microvesiclesliterature in other cell types,56,57 including human monocytes,5
we found that exposure of THP-1 macrophages to TSE for
20 hours increased the phosphorylation of three major MAPKs
(ie, JNK, p38, and ERK) (Figure 4A). The biphasic ERK
response in Figure 4A was reproducible and resembles ERK
activation in some,58,59 but not all,5 other circumstances. In
primary hMDMs, TSE also activated all three MAPKs, but the
activation occurred later than in THP-1 macrophages and per-
sisted to the 6-hour time point (Figure 4B). Pretreatment of the
THP-1macrophageswith either the JNK inhibitor SP600125or
the p38 inhibitor SB202090 completely blocked the ability of
smoke to induce MMP14 expression, indicating that activation
of both kinases is required (Figure 4C). The ERK inhibitor
(U0126)had no detectable effect, indicatingpathway speciﬁcity
(Figure4C).A similar patternwas evident for the effects of these
MAPK inhibitors on TSE-induced expression of MMP14 by
primary hMDMs, indicating roles for JNKandp38but notERK
(Figure 4D). The involvement ofMAPK signaling pathways in
expression ofMMP14bymacrophages had not beenpreviously
reported, although severalprior studies founda role for JNK,but
not ERK, in MMP14 induction in other cell types exposed to
other stimuli, consistent with our current results.45,60,61
Next we examined the role of MAPKs in TSE-induced
apoptosis and the generation of MMP14-positive MVs from
human macrophages. Our recent work in human monocytes
showed that tobacco smoke-induced apoptosis and apoptotic
MV generation is mediated through ERK in those cells.5
Unexpectedly, pretreatment of human THP-1 macrophages
with the JNK or p38 inhibitor provided signiﬁcant protection
from TSE-induced apoptosis, whereas the ERK inhibitor had
no effect (Figure 5A and Supplemental Figure S3A). A similar
patternwas evident for the effects of theseMAPKinhibitors on
TSE-induced apoptosis of primary hMDMs (Figure 5B).
Likewise, inhibition of JNK or p38 inhibited smoke-induced
production of total and MMP14-positive MVs from both
THP-1macrophages (Figure 5, C andD) and primary hMDMs
(Figure 5E), again indicating a need for activation of both of
these kinases for these effects to occur in macrophages. Inhi-
bition of ERK, however, had no detectable effect on any of
these parameters, demonstrating pathway and cell-type spec-
iﬁcity (Figure 5, AeE, and Supplemental Figure S3, A andB),
consistent with the extensive changes that occur during
monocyte-to-macrophage differentiation.62e65
Finally, we tested the role of MAPKs in the generation of
proteolytic MVs from smoke-exposed human macrophages.
Pretreatment of THP-1 macrophages with MAPK inhibitors
was followed by exposure to TSE for 20 hours and then ultra-
centrifugal isolation ofMVs fromconditionedmedia. Inhibition
of JNK or p38, but not ERK, completely blocked TSE-induced
production of MVs with proteolytic activities against ﬂuoro-
genic substrate I (Figure 6A), gelatin (Figure 6B), and native
collagen (Figure 6C). These results indicate that activation of
the JNK and p38 signaling pathways is responsible for the TSE-
induced generation of proteolytically active MVs from human
macrophages through activation of MMP14 expression,
apoptosis, and membrane blebbing.The American Journal of Pathology - ajp.amjpathol.orgDiscussion
Our studydemonstrates that exposure of humanmacrophages to
tobacco smoke extract induces the release of potently proteo-
lytic MVs. We found that smoke-induced macrophage MVs
carry substantial gelatinolytic and collagenolytic activities
that can be attributed, surprisingly, predominantly to a single
transmembrane protease of the MMP superfamily e namely,
MMP14. Based on our biochemical andmorphological studies,
the production of these MVs relies on a series of dynamic,
regulated steps that include activation of the JNK and p38
MAPKs, MAPK-dependent induction of cellular MMP14,
cleavage of pro-MMP14 into its active mature form, a remark-
able accumulation of MMP14 into nascent plasma membrane
blebs, and ﬁnally, caspase- and MAPK-dependent apoptosis
and apoptotic blebbing.1559
Li et alMMP14 is of particular relevance to unstable atheroscle-
rosis, given the ability of the enzyme to disrupt collagen
within murine plaques in vivo43 and its abundance within
human atheromata,41 particularly in macrophages within the
rupture-prone shoulders of advanced plaques47 Of note,
apoptotic macrophages have been found at sites of plaque
rupture in sudden coronary death,66 consistent with the
production of biologically active MVs. Moreover, MMP14 has
been reported to activate the gelatinase MMP242 and destroy
apolipoprotein E,67 a protein with anti-atherogenic properties
when expressed by macrophages.68 In addition, emphysema-
tous lungs exhibit upregulation of MMP14 in alveolar
macrophages,13,45,46 a cell type directly exposed to cigarette
smoke and prone to apoptosis.53 Taken together, TSE-induced
expression of MMP14 by human macrophages and then its
release oncollagenolyticMMP14-positiveMVsmaycontribute
to the conspicuous instability of atherosclerotic plaques and the
destruction of pulmonary connective tissue in smokers. High
levels of MMP14 on cells and on MVs may also contribute to
other complications of smoking, suchas loss of dermal collagen.
Each activated or apoptotic cell can release many MVs,
and owing to their small size, the MVs often survive longer
and diffuse more readily than their parental cells.7,69,70
Overall, the ability of TSE to induce expression of MMP14
by human macrophages and then the activation and export of
this molecule on MVs may be a particularly potent pathway
to damage extracellular matrix in tissues and organs of
individuals exposed to tobacco smoke.
Supplemental Data
Supplemental material for this article can be found at
http://dx.doi.org/10.1016/j.ajpath.2013.01.035.
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